|
JPS5953920B2
(ja)
*
|
1977-12-28 |
1984-12-27 |
東洋醸造株式会社 |
新規なアミノ糖化合物およびその製法
|
|
DE3439008A1
(de)
*
|
1984-10-25 |
1986-04-30 |
Bayer Ag, 5090 Leverkusen |
Polymerisate zur reinigung von acarbose
|
|
DE3543999A1
(de)
*
|
1985-12-13 |
1987-06-19 |
Bayer Ag |
Hochreine acarbose
|
|
ES2056801T3
(es)
*
|
1986-08-13 |
1994-10-16 |
Hoechst Ag |
Oxirano-seudooligosacaridos, procedimiento para su preparacion, su utilizacion y preparados farmaceuticos.
|
|
DE19637591A1
(de)
*
|
1996-09-13 |
1998-03-19 |
Bayer Ag |
Osmokontrolliertes Fermentationsverfahren zur Herstellung von Acarbose
|
|
YU52199A
(sh)
*
|
1997-04-15 |
2003-02-28 |
Csir Corporate Building |
Farmaceutske kompozicije za suzbijanje apetita
|
|
IT1293819B1
(it)
*
|
1997-08-05 |
1999-03-10 |
Univ Massachusetts Lowell |
Procedimento per la preparazione di acarbosio
|
|
AUPP521298A0
(en)
*
|
1998-08-12 |
1998-09-03 |
Life Therapeutics Limited |
Purification of fibrinogen
|
|
AUPP790898A0
(en)
|
1998-12-23 |
1999-01-28 |
Life Therapeutics Limited |
Renal dialysis
|
|
US20050224355A1
(en)
*
|
1999-12-23 |
2005-10-13 |
Brendon Conlan |
Removal of biological contaminants
|
|
AUPP790698A0
(en)
|
1998-12-23 |
1999-01-28 |
Life Therapeutics Limited |
Separation of microorganisms
|
|
GB2396815B
(en)
*
|
1999-10-27 |
2004-09-08 |
Phytopharm Plc |
A composition comprising a pregnenone derivative and an NSAID
|
|
AU7457300A
(en)
*
|
1999-10-28 |
2001-05-08 |
Chong Kun Dang Pharmaceutical Corp. |
A process for preparing acarbose with high purity
|
|
US7077942B1
(en)
|
1999-12-23 |
2006-07-18 |
Gradipore Limited |
Removal of biological contaminants
|
|
AUPQ691400A0
(en)
*
|
2000-04-14 |
2000-05-11 |
Life Therapeutics Limited |
Separation of micromolecules
|
|
AUPQ697300A0
(en)
|
2000-04-18 |
2000-05-11 |
Life Therapeutics Limited |
Separation apparatus
|
|
ATE449200T1
(de)
|
2000-04-18 |
2009-12-15 |
Gradipore Ltd |
Trennung und behandlung von proben durch elektrophorese
|
|
GB2363985B
(en)
|
2000-06-30 |
2004-09-29 |
Phytopharm Plc |
Extracts,compounds & pharmaceutical compositions having anti-diabetic activity and their use
|
|
WO2002012256A1
(en)
*
|
2000-08-07 |
2002-02-14 |
Biogal Gyogyszergyar Rt |
Method for purification of acarbose
|
|
US6923896B2
(en)
*
|
2000-09-22 |
2005-08-02 |
The Texas A&M University System |
Electrophoresis apparatus and method
|
|
DE60142520D1
(de)
*
|
2000-10-06 |
2010-08-19 |
Arturus Capital Ltd |
Multi-port-elektrophorese-trennvorrichtung und entsprechendes verfahren
|
|
AUPR222300A0
(en)
*
|
2000-12-21 |
2001-01-25 |
Life Therapeutics Limited |
Electrophoresis device and method
|
|
HRP20010792A2
(en)
|
2001-10-26 |
2003-04-30 |
Pliva D D |
Acarbose purification process
|
|
US7320998B1
(en)
*
|
2003-07-11 |
2008-01-22 |
Chymos Corporation |
Carbohydrate analog inhibitors of alpha-amylase
|
|
US20050288340A1
(en)
*
|
2004-06-29 |
2005-12-29 |
Pfizer Inc |
Substituted heteroaryl- and phenylsulfamoyl compounds
|
|
DE602005016009D1
(de)
*
|
2004-11-23 |
2009-09-24 |
Warner Lambert Co |
7-(2h-pyrazol-3-yl)-3,5-dihydroxy-heptansäure-derivate als hmg-co-a-reductase-inhibitoren zur behandlung von lipidemia
|
|
US7741317B2
(en)
|
2005-10-21 |
2010-06-22 |
Bristol-Myers Squibb Company |
LXR modulators
|
|
US7888376B2
(en)
|
2005-11-23 |
2011-02-15 |
Bristol-Myers Squibb Company |
Heterocyclic CETP inhibitors
|
|
JP2007323865A
(ja)
*
|
2006-05-30 |
2007-12-13 |
Sumitomo Metal Electronics Devices Inc |
同軸コネクタとそれを用いた半導体素子収納用パッケージとこれらに接続される同軸アダプタ
|
|
WO2008070496A2
(en)
|
2006-12-01 |
2008-06-12 |
Bristol-Myers Squibb Company |
N- ( (3-benzyl) -2, 2- (bis-phenyl) -propan-1-amine derivatives as cetp inhibitors for the treatment of atherosclerosis and cardiovascular diseases
|
|
JP2010520913A
(ja)
|
2007-03-12 |
2010-06-17 |
サズセ アーペーエス |
ルイボスの抗糖尿病性抽出物
|
|
US8969514B2
(en)
|
2007-06-04 |
2015-03-03 |
Synergy Pharmaceuticals, Inc. |
Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
|
|
ES2393885T7
(es)
|
2007-06-04 |
2014-01-30 |
Synergy Pharmaceuticals Inc. |
Agonistas de la guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros trastornos
|
|
WO2009149279A2
(en)
|
2008-06-04 |
2009-12-10 |
Synergy Pharmaceuticals Inc. |
Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
|
|
AU2009270833B2
(en)
|
2008-07-16 |
2015-02-19 |
Bausch Health Ireland Limited |
Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
|
|
CA2799708A1
(en)
|
2010-05-21 |
2011-11-24 |
Pfizer Inc. |
2-phenyl benzoylamides
|
|
US20130156720A1
(en)
|
2010-08-27 |
2013-06-20 |
Ironwood Pharmaceuticals, Inc. |
Compositions and methods for treating or preventing metabolic syndrome and related diseases and disorders
|
|
US9616097B2
(en)
|
2010-09-15 |
2017-04-11 |
Synergy Pharmaceuticals, Inc. |
Formulations of guanylate cyclase C agonists and methods of use
|
|
WO2012120414A2
(en)
|
2011-03-04 |
2012-09-13 |
Pfizer Inc. |
Edn3-like peptides and uses thereof
|
|
WO2013133685A1
(en)
|
2012-03-09 |
2013-09-12 |
Biotropics Malaysia Berhad |
Extract formulations of rhodamnia cinerea and uses thereof
|
|
WO2014151206A1
(en)
|
2013-03-15 |
2014-09-25 |
Synergy Pharmaceuticals Inc. |
Agonists of guanylate cyclase and their uses
|
|
US9486494B2
(en)
|
2013-03-15 |
2016-11-08 |
Synergy Pharmaceuticals, Inc. |
Compositions useful for the treatment of gastrointestinal disorders
|
|
JP2016516804A
(ja)
|
2013-04-17 |
2016-06-09 |
ファイザー・インク |
心血管疾患を治療するためのn−ピペリジン−3−イルベンズアミド誘導体
|
|
EP3004138B1
(en)
|
2013-06-05 |
2024-03-13 |
Bausch Health Ireland Limited |
Ultra-pure agonists of guanylate cyclase c, method of making and using same
|
|
MX389591B
(es)
|
2014-08-29 |
2025-03-20 |
Tes Pharma S R L |
INHIBIDORES DE ACIDO A-AMINO-ß-CARBOXIMUCONICO SEMIALDEHIDO DESCARBOXILASA
|
|
WO2016055901A1
(en)
|
2014-10-08 |
2016-04-14 |
Pfizer Inc. |
Substituted amide compounds
|
|
US20180134667A1
(en)
|
2016-10-14 |
2018-05-17 |
TES Pharma S.r.I. |
Inhibitors of alpha-amino-beta-carboxymuconic acid semialdehyde decarboxylase
|
|
AR117122A1
(es)
|
2018-11-20 |
2021-07-14 |
Tes Pharma S R L |
INHIBIDORES DE LA ÁCIDO a-AMINO-b-CARBOXIMUCÓNICO SEMIALDEHÍDO DESCARBOXILASA
|
|
BR112021013807A2
(pt)
|
2019-01-18 |
2021-11-30 |
Astrazeneca Ab |
Inibidores de pcsk9 e seus métodos de uso
|